Company Profile for Amneal Pharmaceuticals

Rhea-AI Summary

Amneal Pharmaceuticals (NYSE: AMRX), based in Bridgewater, NJ, is a fully-integrated pharmaceutical company engaged in developing, manufacturing, and distributing generic and specialty drugs. With a portfolio of around 250 product families, the company also focuses on complex dosage forms and branded products in central nervous system and endocrine disorders. Owning 65% of AvKARE, Amneal primarily serves governmental agencies, including the Department of Defense and Veterans Affairs. The company is expanding its reach across North America, Asia, and Europe to deliver high-quality medicines.

Positive

• Extensive portfolio of ~250 product families.
• Focus on complex dosage forms, including biosimilars.
• 65% ownership of AvKARE enhances market reach.

Negative

• None.

--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE:AMRX), headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

Amneal has an extensive portfolio of approximately 250 product families and is expanding its portfolio to include complex dosage forms, including biosimilars, in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty segment focused principally on central nervous system and endocrine disorders.

The Company also owns 65% of AvKARE. AvKARE provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, primarily focused on serving the Department of Defense and the Department of Veterans Affairs. AvKARE is also a packager and wholesale distributor of pharmaceuticals and vitamins to its retail and institutional customers who are located throughout the United States focused primarily on offering 340b-qualified entities products to provide consistency in care and pricing.

Company:		Amneal Pharmaceuticals
Headquarters Address:		400 Crossing Blvd.
		Oakland, NJ 08807
Main Telephone:		908-947-3120
Website:		www.amneal.com
Ticker:		AMRX(NYSE)
Type of Organization:		Public
Industry:		Pharmaceutical
Key Executives:		President & Co-CEO: Chirag Patel
		Co-CEO: Chintu Patel
		CFO: Tasos Konidaris
Investor Relations
Contact:		Investor Relations
Phone:		908-947-3120
Email:		Invest@amneal.com
Public Relations
Contact:		Media Relations
Phone:		908-947-3120
Email:		MediaRelations@amneal.com